The China arthroscopy market size was valued at USD 291.6 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.6% from 2020 to 2027. The market is gaining momentum and witnessing a high demand owing to the increasing prevalence of arthritis and growing joint surgeries, increasing incidence of sports injuries, and increasing penetration of minimally invasive procedures.
The increasing prevalence of arthritis and the growing volume of joint surgical procedures in China is driving the market for arthroscopy. In 2015, the prevalence of arthritis amongst middle-aged and older adults in China was around 31.4%. Also, prevalence of knee OA was around 8.8% (women: 11.0% men: 6.3%), and the total number of knee OA cases in China was 37,542,017 (men: 12,888,827, women: 24,653,190) according to Osteoarthritis Research Society International (OARSI). Furthermore, in 2018, around 300,000 hip replacement surgeries were performed in China.
Estimates published by the WHO suggest that the Chinese population aged 65 and over is projected to increase from 12.4% in 2010 to 28% in 2040. An increase in the geriatric population is expected to lead to a rise in the incidence of obesity and arthritis. An increase in the target population along with a growing preference for minimally invasive surgical procedures is expected to significantly propel the demand for arthroscopy over the forecast period.
Many minimally invasive procedures such as arthroscopy can be performed by using a tiny camera called an arthroscope. The increasing preference for minimally invasive arthroscopic surgeries is expected to contribute to market growth.
However, due to the COVID-19 pandemic, elective surgeries related to the knee, shoulder, and hip were postponed. This scenario resulted in slightly lower revenue growth of some market players in 2020.Market players such as Stryker and Smith & Nephew plc experienced a decrease in the demand for arthroscopy devices, among other orthopedic products.
The ablation systems segment dominated the market for arthroscopy and accounted for the largest revenue share of over 45.0% in 2019. Ablation systems are commonly used during arthroscopic surgeries for the removal of soft tissue. The ablations systems segment is driven by factors such as the rising prevalence of chronic pain disorders such as osteoporosis and arthritis and preference for minimally invasive surgeries.In July 2015, Johnson & Johnson (Mitek Sports Medicine) launched VAPR radiofrequency tools (the VAPR TRIPOLAR 90 and VAPR ARCTIC Suction Electrode) to improve soft tissue coagulation and ablation during arthroscopy.
The knee segment dominated the market for arthroscopy and accounted for the largest revenue share of 49.0% in 2019. Knee arthroscopy procedures can be utilized for cruciate ligament reconstruction, cruciate ligament repair, chondroplasty, meniscus repair, removal of loose fragments, and release or excision of tight structures.
The increasing prevalence of knee arthritis, technological advancements, and rapid adoption of arthroscopes in joint replacement surgeries for precision are major factors likely to drive the market for arthroscopy. The increasing prevalence of knee arthritis, technological advancements, and rapid adoption of arthroscopes in joint replacement surgeries for precision are major factors likely to drive the market.
Vendors are investing in product launches, geographical expansions, collaborative agreements, and acquisitions, to sustain in the market for arthroscopy. The market for capnography devices is expected to become highly competitive as many startups are seeking opportunities in this sector.The presence of several global and regional players that provide similar products has led to high competition among market vendors.The market for arthroscopy devices in China is expected to become highly competitive as many local players are seeking opportunities in this sector.
For instance,in July 2020, Smith & Nephew Plc. launched RI.HIP NAVIGATION for Total Hip Arthroplasty (THA). This technology was developed to help maximize reproducibility and accuracy by delivering patient-specific component alignment, a key factor for surgeons when evaluating specific THA cases. Also, in December 2020, Arthrex launched SwiveLock anchor for ACL repair. It was the first and only FDA-cleared equipment for the primary repair of ACL tears. Some of the prominent players in the China arthroscopy market include:
Zhejiang Shendasiao Medical Instrument Co., Ltd.
Xuzhou Hengjia Electronic Technology Co., Ltd.
Tonglu Wanhe Medical Instrument Co., Ltd.
Smith & Nephew plc
Johnson & Johnson
Market size value in 2020
USD 309.8 million
Revenue forecast in 2027
USD 485.9 million
CAGR of 6.6% from 2020 to 2027
Base year for estimation
2016 - 2018
2020 - 2027
Revenue in USD million and CAGR from 2020 to 2027
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Key companies profiled
Zhejiang Shendasiao Medical Instrument Co., Ltd.; TITMED; Shrek; Xuzhou Hengjia Electronic Technology Co., Ltd.; Tonglu Wanhe Medical Instrument Co., Ltd.; Stryker; Smith & Nephew plc; Zimmer Biomet; Johnson & Johnson; Arthrex, Inc.
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the China arthroscopy market report on the basis of product and application:
Product Outlook (Revenue, USD Million, 2016 - 2027)
Powered Shaver Systems
Fluid Management Systems
Accessories and Disposables
Application Outlook (Revenue, USD Million, 2016 - 2027)
Foot and Ankle
Hand and Wrist
b. The ablation systems segment dominated the market for arthroscopy in China and accounted for the largest revenue share of over 45.0% in 2019.
b. The China arthroscopy market was estimated at USD 291.6 million in 2019 and is expected to reach USD 309.8 million in 2020.
b. China arthroscopy market is expected to grow at a compound annual growth rate of 6.6% from 2020 to 2027 to reach USD 485.9 million by 2027.
b. Knee arthroscopy dominated the applications segment in the China arthroscopy market with a share of 49% in 2019. This is attributable to the increasing prevalence of knee arthritis in China.
b. Some key players operating in the China arthroscopy market include Zhejiang Shendasiao Medical Instrument Co., Ltd; TITMED; Shrek; Xuzhou Hengjia Electronic Technology Co., Ltd; Tonglu WANHE Medical Instrument Co., Ltd; Stryker; Smith & Nephew plc; Zimmer Biomet; Johnson & Johnson; and Arthrex, Inc.
b. Key factors that are driving the China arthroscopy market growth include the increasing prevalence of knee arthritis, growing demand for rowing joint surgery, rising incidence of sports injuries, and increasing penetration of minimally invasive procedures.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."